It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
The regular practice of physical activity is considered a health promoter and appears to be one of the main contributors to the prevention of chronic diseases. However, the potential effects of exercise on health depending on the time of day at which it is performed have not yet been fully elucidated.
ObjectivesTo evaluate the effect of physical exercise (aerobic or anaerobic) and chronobiology (morning or afternoon) on the glycemic metabolism of healthy subjects.
MethodsHealthy subjects participated in aerobic or anaerobic physical exercise sessions, either in the morning or in the afternoon. Blood was drawn from the subjects before, at the end of the exercise and 2 hours after the end of the exercise. Glycemic parameters were analyzed at these time points. A general linear model test was performed after verifying the normal distribution of the raw data (as assessed by the Shapiro-Wilk test) or after a logarithmic/square root transformation, considering aerobic or anaerobic exercise and morning or afternoon exercise as independent variables.
ResultsTwenty-three subjects (14 women and 9 men) were included in the study. The rate of change in glucose levels was significantly higher at the end of anaerobic exercise compared to aerobic exercise (1.19 ± 0.04 vs. 0.98 ± 0.02, respectively), with a more pronounced decrease in insulin and C-peptide levels following aerobic exercise. In addition, the increase of glucose was higher after the exercise in the morning compared with the afternoon (1.14 ± 0.03 vs. 1.03 ± 0.03, respectively).
ConclusionsThe type of exercise and chronobiology influence short-term glucose metabolism.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; Faculty of Health Sciences, University of Malaga, Spain
2 Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain
3 Department of Human Physiology, Physical Education and Sport, Faculty of Medicine, University of Malaga, Malaga, Spain; Internal Medicine Department, Regional University Hospital of Málaga; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Malaga, Spain
4 Department of Human Physiology, Physical Education and Sport, Faculty of Medicine, University of Malaga, Malaga, Spain
5 Department of Cardiology and Cardiovascular Surgery, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; Biomedical Research Network Center for Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain
6 Clinical Analysis UGC, Virgen de la Victoria University Hospital, Málaga, Spain; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Hospital Clínico Virgen de la Victoria, Malaga, Spain
7 Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Malaga, Spain; Department of Dermatology and Medicine, Faculty of Medicine, University of Malaga, Malaga, Spain
8 Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Malaga, Spain
9 Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Malaga, Spain; Department of Cardiology and Cardiovascular Surgery, Virgen de la Victoria University Hospital; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Malaga, Spain